BNT331
- Generic Name
- BNT331
A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- BioNTech SE
- Target Recruit Count
- 102
- Registration Number
- NCT06469164
- Locations
- 🇺🇸
UAB Sexual Health Research Clinic, Birmingham, Alabama, United States
🇺🇸Praetorian Pharmaceutical Research, LLC, Marrero, Louisiana, United States
🇺🇸Southern Clinical Research Associates - Metairie, Metairie, Louisiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath